Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

85 recruitingLast updated: June 17, 2026

There are 85 actively recruiting chronic obstructive pulmonary disease (copd) clinical trials across 51 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1, Phase 4. Top locations include Baltimore, Maryland, United States, Houston, Texas, United States, Hong Kong, Hong Kong. Updated daily from ClinicalTrials.gov.


Chronic Obstructive Pulmonary Disease (COPD) Trials at a Glance

85 actively recruiting trials for chronic obstructive pulmonary disease (copd) are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 22 trials, with the heaviest enrollment activity in Baltimore, Houston, and Hong Kong. Lead sponsors running chronic obstructive pulmonary disease (copd) studies include AstraZeneca, ADIR Association, and Beijing Chao Yang Hospital.

Browse chronic obstructive pulmonary disease (copd) trials by phase

Treatments under study

About Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Looking for clinical trials for Chronic Obstructive Pulmonary Disease (COPD)? There are currently 114 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Obstructive Pulmonary Disease (COPD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Obstructive Pulmonary Disease (COPD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 85 trials

Recruiting
Not Applicable

Mindful-Breath for People With COPD

MindfulnessChronic Obstructive Pulmonary Disease (COPD)Pulmonary Rehabilitation
The University of Hong Kong60 enrolled1 locationNCT07195838
Recruiting

Breathlessness Perceptions Within Respiratory Diseases

Chronic Obstructive Pulmonary Disease (COPD)BronchiectasisAsthma (Diagnosis)+2 more
University Hospitals, Leicester75 enrolled1 locationNCT07648082
Recruiting

Measurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality

Chronic Obstructive Pulmonary Disease (COPD)Cardiovascular DiseaseType 2 Diabetes
Steno Diabetes Center Copenhagen194 enrolled1 locationNCT07641309
Recruiting
Phase 2

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca987 enrolled366 locationsNCT07082738
Recruiting
Not Applicable

Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
ADIR Association33 enrolled1 locationNCT06956742
Recruiting

Study of Patient With Frequent Exacerbations in Moscow

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca500 enrolled1 locationNCT07307781
Recruiting
Not Applicable

Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation

Acute Coronary SyndromeChronic Obstructive Pulmonary Disease (COPD)Fragility Fracture+1 more
Matthias Wilhelm, MD240 enrolled2 locationsNCT07597031
Recruiting

D-RSBI Versus RSBI for Predicting Weaning Success in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)Mechanical Ventilator Weaning
Sohag University100 enrolled1 locationNCT07590362
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled301 locationsNCT06883305
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled268 locationsNCT06878261
Recruiting
Not Applicable

Pulmonary Rehabilitation for Rural Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)
Mayo Clinic306 enrolled2 locationsNCT06847061
Recruiting
Phase 1

Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:

Chronic Obstructive Pulmonary Disease (COPD)With Poitive H Pylori
Zagazig University54 enrolled1 locationNCT07574879
Recruiting

Investigating the use of humidified high flow therapy (supplemental oxygen optional) in the home setting for patients with existing lung disease (Chronic Obstructive Pulmonary Disease (COPD) or Bronchiectasis). The DOMINO Study

Chronic Obstructive Pulmonary Disease (COPD)Bronchiectasis
Metro North Hospital and Health Services60 enrolled2 locationsACTRN12626000558325
Recruiting
Phase 2

Phase II Study of RC1416 Injection in COPD

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled41 locationsNCT07402551
Recruiting

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

Chronic Obstructive Pulmonary Disease (COPD)
Sanofi500 enrolled22 locationsNCT07380711
Recruiting

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

Chronic Obstructive Pulmonary Disease (COPD)PneumoniaInfection+6 more
National University Hospital, Singapore220 enrolled1 locationNCT07536035
Recruiting
Not Applicable

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

Heart FailureCancerDiabetes+4 more
Amager Hospital2,800 enrolled1 locationNCT07518446
Recruiting
Not Applicable

Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program

Chronic Obstructive Pulmonary Disease (COPD)Frailty
National Geriatric Hospital80 enrolled2 locationsNCT07519603
Recruiting
Phase 3

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Not Applicable

Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia

Chronic respiratory failureInterstitial Lung DiseaseChronic Obstructive Pulmonary Disease (COPD)+1 more
Istituti Clinici Scientifici Maugeri SpA114 enrolled6 locationsNCT07451977